cilostazol has been researched along with beraprost in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fujitani, K; Kambayashi, J; Kawasaki, T; Murata, K; Murata, T; Sakon, M; Shiba, E; Shinozaki, K; Yano, Y; Yukawa, M | 1 |
| Hayakawa, T; Inada, M; Miyake, Y; Nishikawa, M; Omoto, S; Shimizu, H; Shouzu, A | 1 |
| Hashiguchi, M; Ohno, K; Saito, R | 1 |
| Ando, M; Hida, K; Ishida, A; Kawasaki, T; Matsumoto, T; Matsuzaki, K; Miyata, T; Nishibe, T; Obitsu, Y; Ohta, T; Shigematsu, H; Shindo, S; Yasugi, T | 1 |
| Hidaka, S; Kobayashi, S; Kondoh, M; Miyaji, T; Moriya, H; Nakazawa, R; Ohtake, T; Sato, M | 1 |
| Cao, Y; Liang, X; Wang, Y; Zhao, C | 1 |
2 review(s) available for cilostazol and beraprost
| Article | Year |
|---|---|
Studies on the effectiveness and safety of cilostazol, beraprost sodium, prostaglandin E1 for the treatment of intermittent claudication.
Topics: Alprostadil; Cilostazol; Epoprostenol; Humans; Intermittent Claudication; Platelet Aggregation Inhibitors; Tetrazoles; Treatment Outcome; Walking | 2004 |
Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis.
Topics: Cilostazol; Humans; Intermittent Claudication; Network Meta-Analysis; Pentoxifylline; Randomized Controlled Trials as Topic; Vasodilator Agents | 2022 |
3 trial(s) available for cilostazol and beraprost
| Article | Year |
|---|---|
Clinical evaluation on combined administration of oral prostacyclin analogue beraprost and phosphodiesterase inhibitor cilostazol.
Topics: Adult; Blood Platelets; Cilostazol; Collagen; Cyclic AMP; Epoprostenol; Headache; Heart Rate; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles | 1995 |
Effects of beraprost and cilostazol and renal function on serum thrombomodulin levels in diabetic patients.
Topics: Cilostazol; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Epoprostenol; Humans; Kidney Function Tests; Platelet Aggregation Inhibitors; Tetrazoles; Thrombomodulin | 2000 |
Randomized pilot trial between prostaglandin I2 analog and anti-platelet drugs on peripheral arterial disease in hemodialysis patients.
Topics: Aged; Aged, 80 and over; Cilostazol; Epoprostenol; Female; Heart Rate; Humans; Male; Microcirculation; Middle Aged; Peripheral Arterial Disease; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Quality of Life; Renal Dialysis; Succinates; Tetrazoles; Treatment Outcome | 2014 |
1 other study(ies) available for cilostazol and beraprost
| Article | Year |
|---|---|
Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Cilostazol; Disease Progression; Epoprostenol; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Quality of Life; Risk Assessment; Risk Factors; Severity of Illness Index; Societies, Medical; Tetrazoles; Time Factors; Treatment Outcome; Vascular Surgical Procedures; Vasodilator Agents | 2010 |